Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 284

1.

Clozapine Therapy and CYP2D6, CYP1A2, and CYP3A4 Genotypes.

Dean L.

In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2016 Jun 8.

2.

Clinical role of brexpiprazole in depression and schizophrenia.

Parikh NB, Robinson DM, Clayton AH.

Ther Clin Risk Manag. 2017 Mar 10;13:299-306. doi: 10.2147/TCRM.S94060. eCollection 2017. Review.

3.

An update on the advancements in the treatment of agitation in Alzheimer's disease.

Porsteinsson AP, Antonsdottir IM.

Expert Opin Pharmacother. 2017 Apr;18(6):611-620. doi: 10.1080/14656566.2017.1307340. Epub 2017 Mar 28. Review.

PMID:
28300462
4.

[Pancreatic encephalopathy: about 2 cases and review of the literature].

Doghmi N, Benakrout A, Meskine A, Bensghir M, Baite A, Haimeur C.

Pan Afr Med J. 2016 Nov 11;25:147. doi: 10.11604/pamj.2016.25.147.9324. eCollection 2016. Review. French.

5.

Best Practices for Managing Pain, Sedation, and Delirium in the Mechanically Ventilated Patient.

Garrett KM.

Crit Care Nurs Clin North Am. 2016 Dec;28(4):437-450. doi: 10.1016/j.cnc.2016.07.004. Epub 2016 Oct 27. Review.

PMID:
28236391
6.

Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.

Pagsberg AK, Tarp S, Glintborg D, Stenstrøm AD, Fink-Jensen A, Correll CU, Christensen R.

J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):191-202. doi: 10.1016/j.jaac.2016.12.013. Epub 2016 Dec 29. Review.

PMID:
28219485
7.

The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.

de Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, Valchera A, Carano A, Vellante F, Marini S, Piersanti M, Perna G, Martinotti G, Di Giannantonio M.

Int J Mol Sci. 2017 Feb 8;18(2). pii: E349. doi: 10.3390/ijms18020349. Review.

8.

Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology.

Rasmussen SA, Mazurek MF, Rosebush PI.

World J Psychiatry. 2016 Dec 22;6(4):391-398. doi: 10.5498/wjp.v6.i4.391. eCollection 2016 Dec 22. Review.

9.

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy.

Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R.

Core Evid. 2016 Dec 14;11:49-61. doi: 10.2147/CE.S114094. eCollection 2016. Review.

10.

Brexpiprazole for the treatment of schizophrenia.

Hsu WY, Lane HY, Lin CH.

Expert Opin Pharmacother. 2017 Feb;18(2):217-223. doi: 10.1080/14656566.2016.1274972. Epub 2017 Jan 16. Review.

PMID:
27997809
11.

Droperidol for psychosis-induced aggression or agitation.

Khokhar MA, Rathbone J.

Cochrane Database Syst Rev. 2016 Dec 15;12:CD002830. doi: 10.1002/14651858.CD002830.pub3. Review.

PMID:
27976370
12.

Cariprazine for Schizophrenia and Bipolar Disorder.

Scarff JR.

Innov Clin Neurosci. 2016 Oct 1;13(9-10):49-52. eCollection 2016 Sep-Oct. Review.

13.

Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis.

Yoon S, Jeon SW, Ko YH, Patkar AA, Masand PS, Pae CU, Han C.

J Clin Psychopharmacol. 2017 Feb;37(1):46-53. doi: 10.1097/JCP.0000000000000622. Review.

PMID:
27941419
14.

Agitation in Patients Recovering From Traumatic Brain Injury: Nursing Management.

Mortimer DS, Berg W.

J Neurosci Nurs. 2017 Feb;49(1):25-30. doi: 10.1097/JNN.0000000000000253. Review.

PMID:
27941413
15.

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

Garay RP, Grossberg GT.

Expert Opin Investig Drugs. 2017 Jan;26(1):121-132. doi: 10.1080/13543784.2017.1267726. Epub 2016 Dec 11. Review.

PMID:
27936965
16.

Haloperidol plus promethazine for psychosis-induced aggression.

Huf G, Alexander J, Gandhi P, Allen MH.

Cochrane Database Syst Rev. 2016 Nov 25;11:CD005146. Review.

PMID:
27885664
17.

Dopamine depleters in the treatment of hyperkinetic movement disorders.

Jankovic J.

Expert Opin Pharmacother. 2016 Dec;17(18):2461-2470. Review.

PMID:
27819145
18.

Emergence Delirium in Pediatric Anesthesia.

Moore AD, Anghelescu DL.

Paediatr Drugs. 2017 Feb;19(1):11-20. doi: 10.1007/s40272-016-0201-5. Review. Erratum in: Paediatr Drugs. 2017 Apr 26;:. Paediatr Drugs. 2017 Jun;19(3):267.

PMID:
27798810
19.

Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required.

Nevels RM, Gontkovsky ST, Williams BE.

Psychopharmacol Bull. 2016 Mar 1;46(1):77-104. Review.

20.

Chemical agents for the sedation of agitated patients in the ED: a systematic review.

Korczak V, Kirby A, Gunja N.

Am J Emerg Med. 2016 Dec;34(12):2426-2431. doi: 10.1016/j.ajem.2016.09.025. Epub 2016 Sep 16. Review.

PMID:
27707527

Supplemental Content

Loading ...
Support Center